Deleterious effects of calcium channel blockade on pressure transmission and glomerular injury in rat remnant kidneys.
Hypertensive mechanisms are postulated to play a major role in the progressive glomerulosclerosis (GS) after renal mass reduction. But, in contrast to converting enzyme inhibitors, BP reduction by calcium channel blockers, has not provided consistent protection. Radiotelemetric BP monitoring for 7 wk was used to compare nifedipine (N) and enalapril (E) in the rat approximately 5/6 renal ablation model. After the first week, rats received N, E, or no treatment (C). The overall averaged systolic BP in C (173 +/- 7 mmHg) was reduced by both E and N (P < 0.001), but E was more effective (113 +/- 2 vs. 134 +/- 3 mmHg, P < 0.01). GS was prevented by E (2 +/- 1 vs. 26 +/- 5% in C) but not by N (25 +/- 6%). GS correlated well with the overall averaged BP in individual animals of all groups, but the slope of the relationship was significantly steeper in N compared with C+E rats (P < 0.02), suggesting greater pressure transmission to the glomeruli and GS for any given BP. Since autoregulatory mechanisms provide the primary protection against pressure transmission, renal autoregulation was examined at 3 wk in additional rats. Autoregulation was impaired in C rats, was not additionally altered by E, but was completely abolished by N. These data demonstrate the importance of autoregulatory mechanisms in the pathogenesis of hypertensive injury and suggest that calcium channel blockers which adversely affect pressure transmission may not provide protection despite significant BP reduction.
Griffin
K A
KA
Department of Medicine, Loyola University Medical Center, Maywood, Illinois 60153, USA.
Picken
M M
MM
Bidani
A K
AK
D000818:Animals; D004656:Enalapril / Q000009:adverse effects*; D005246:Feedback; D006977:Hypertension, Renal / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D007238:Infarction / Q000503:physiopathology; D007668:Kidney / Q000098:blood supply; D008297:Male; D009392:Nephrectomy / Q000009:adverse effects; D009543:Nifedipine / Q000009:adverse effects*; D051381:Rats; D017207:Rats, Sprague-Dawley
D004656:Enalapril; D009543:Nifedipine